Loading provider…
Loading provider…
Hematology & Oncology Physician in Santa Cruz, CA
NPI: 1063537934Primary Employer
Palo Alto Medial Foundation
sutterhealth.org
HQ Phone
Get DO Glenn's Phone Numberphone_androidMobile
Get DO Glenn's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State License
2007 - 2027
MA State License
2004 - 2009

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
St Elizabeth's Medical Center
Fellowship • Hematology and Medical Oncology
2005 - 2008
Residency • Internal Medicine
2001 - 2004
Touro University California - Vallejo
tu.edu
Medical School
Until 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 385 | 794 |
| 2 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 197 | 465 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 176 | 653 |
| 4 | 96413Infusion of chemotherapy into a vein up to 1 hour | 153 | 381 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 89 | 312 |
Do Deaf and Hard of Hearing Youth Need Antitobacco Education
Authors: Barbara A. Berman, Leanne Streja, Coen A. Bernaards, Elizabeth A. Eckhardt, Heidi B. Kleiger
Authors: Mark Shulman, Thein Oo
Publication Date: 2009-05-12
Authors: Donald Tashkin
Journal: J Immigr Minor Health
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Cyclophosphamide, DRUG: Ibrutinib, DRUG: Fludarabine Phosphate, BIOLOGICAL: Rituximab, OTHER: Pharmacogenomic Study
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, OTHER: Laboratory Biomarker Analysis, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Ibrutinib, BIOLOGICAL: Rituximab, PROCEDURE: Computed Tomography, PROCEDURE: Bone Marrow Aspiration, DRUG: Bendamustine Hydrochloride
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Exemestane, DRUG: Letrozole, DRUG: Anastrozole, DRUG: Tamoxifen Citrate, DRUG: Systemic Chemotherapy